WinstonWınston
StableX Technologies logo

StableX Technologies

SBLX
Auto - Manufacturers · Consumer Cyclical
Price
$2.63
+0.09 (+3.35%)
Market Cap
$1.8M
Exchange
NASDAQ Capital Market
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count falling — buybacks

80.1% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 4.4M (2021) → 875K (2025)

StableX Technologies, Inc. is a small automotive technology company focused on developing vehicle stability and control systems. The company works on hardware and software solutions designed to improve how vehicles handle and stay safe on the road. Its target customers are likely automakers and automotive suppliers in the broader vehicle manufacturing industry.

StableX generates revenue through product sales and potentially licensing its technology to vehicle manufacturers, though its current financials show essentially no revenue and significant losses, suggesting it is still in an early development stage. The company appears to operate primarily in the United States. With a deeply negative return on invested capital of over 125%, the business is burning through cash without yet achieving commercial scale. The primary risk facing StableX is whether it can secure meaningful customer contracts and reach profitability before exhausting its capital, which is a common and serious challenge for pre-revenue automotive technology startups competing against much larger, established suppliers.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

-100.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$1M/ year

Declining (-7% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

6.6%ownership

Insiders own a meaningful stake in the company

Cash Runway

~22 months

$8M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Adequate runway but may need to raise capital within 2 years

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
N/A
Data not available
Operating Margin
N/A
Data not available
ROCE
-21.6%
Weak — -21.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-100.0%
Shrinking sales (-100.0% YoY)
EPS YoY
-100.0%
Earnings shrinking (-100.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial